ClinicalTrials.gg
Not yet recruitingNCT06572124Updated Sep 4, 2024

Clinical Performance of ARS Containing Universal Adhesives in Carious Cervical Lesions

An interventional study of universal adhesive without Acid resistant silane coupling agent and universal adhesive with Acid resistant silane coupling agent in Carious Lesion and Cervical Caries, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to participants aged 21 Years to 67 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-04.

Primary conditionRoot CariesRegistry: Dental CariesReclassifiedWhy we changed it
Registry
Dental Caries — the first condition term the registry derived for this study.
ClinicalTrials.gg
Root Caries
Why
  1. The study's listed conditions name Root Caries, a narrower term within Dental Caries.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
21 Years to 67 Years
Sex
All
01

Study summary

Evaluation of composite restorations done in carious cervical lesions restored by a conventional universal adhesive in comparison to a universal adhesive that contains and resistant silane coupling agent according to the Modified United States Public Health Service (USPHS) criteria over 18 months.

Read the detailed description

The presence of acidic monomers in the bottle during storage can lead to the hydrolysis of silane contained in universal adhesives, potentially reducing its effectiveness and causing instability,The acid resistant silane coupling agent has a protective structure against attacks from acidic monomers. Therefore, long-term storage stability can be expected by suppressing hydrolysis. The protective structure is removed when the concentration of acidic monomers increases by air drying after application. This activates ARS, exerting the silane coupling effect.

02

Conditions studied

  • Carious Lesion
  • Cervical Caries

Browse trials for

03

In context

Root Caries Reclassified

39 studies on the registry are indexed under Root Caries; 14 are open to participants now.

This study's planned enrollment of 80 is above the median of 62 across 35 interventional studies indexed under Root Caries.

Browse Root Caries studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Compared within Root Caries, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Dental Caries. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
21 Years to 67 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants Inclusion:

    • Adults aging from 21-67 years old who were in need of restoration of at least one notch-shaped cervical lesion
  • Teeth Inclusion:

    • Vital teeth with carious cervical lesions in incisors , canines ,premolars\& molars

Exclusion criteria

Exclusion Criteria:

  • Participants Exclusion:

    • Patients with fewer than 20 teeth
    • Poor oral hygiene
    • Uncontrolled periodontal disease
    • Xerostomia
    • Known allergy to resin-based materials
    • Medically compromised, pregnant, or breast-feeding
  • Teeth Exclusion:

    • Non vital teeth
    • Teeth that are out of occlusion
    • Previously restored teeth
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    Universal adhesive without acid resistant silane coupling agent

    Universal adhesive with normal silane (comparator) After the acid etching and rinsing and drying step, the universal adhesive with normal silane will be actively applied for 20 second , then light cured for 20 seconds then the restoration will be placed

    Procedure: universal adhesive without Acid resistant silane coupling agent

  • Experimental
    Universal adhesive with acid resistant silane coupling agent

    Universal adhesive with acid resistant silane coupling agent (Intervention) After the acid etching and rinsing and drying step, the universal adhesive with acid resistant silane coupling agent will be actively applied for 20 second , then light cured for 20 seconds then the restoration will be placed

    Procedure: universal adhesive with Acid resistant silane coupling agent

Interventions

  • Procedureuniversal adhesive without Acid resistant silane coupling agent

    After cavity preparations, enamel margins will be etched for 30 seconds then rinsed and dried, then the Universal adhesive without acid resistant silane coupling agent will be actively applied for 20 seconds then air thinned for 5 seconds then cured for 20 seconds.Then the composite restoration will be placed.

  • Procedureuniversal adhesive with Acid resistant silane coupling agent

    After cavity preparations, enamel margins will be etched for 30 seconds then rinsed and dried, then the Universal adhesive which contains acid resistant silane coupling agent will be actively applied for 20 seconds then air thinned for 5 seconds then cured for 20 seconds.Then the composite restoration will be placed.

06

What researchers measure

Primary outcomes

  1. Retention (Success rate)

    Alpha (A) Present Bravo (B) Partial loss but clinically acceptable Charlie (C)Clinically unacceptable partial loss or absent

    Time frame: T0=baseline 24 hours postoperative. T1=12 months postoperative. T2=18 months postoperative.

Secondary outcomes

  1. Marginal adaptation

    Alpha (A) Restoration adapts closely to the tooth structure; there is no visible crevice. Bravo (B) There is a visible crevice, the explorer will penetrate, without dentin exposure. Charlie(C)The explorer penetrates into a crevice in which dentin or the base is exposed.

    Time frame: T0=baseline 24 hours postoperative. T1=12 months postoperative. T2=18 months postoperative.

  2. Marginal discoloration

    Alpha (A) No marginal discoloration. Bravo (B) Minor marginal discoloration without staining toward the pulp, only visible using a mirror and operating light. Charlie(C) Deep discoloration with staining toward the pulp, visible at a speaking distance of 60 to 100 cm.

    Time frame: T0=baseline 24 hours postoperative. T1=12 months postoperative. T2=18 months postoperative.

  3. Secondary caries

    Alpha (A) No active caries present Charlie(C) Active caries is present in contact with the restoration

    Time frame: T0=baseline 24 hours postoperative. T1=12 months postoperative. T2=18 months postoperative.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06572124
Lead sponsor
Cairo University
Responsible party
Ahmed El-Kotaby (Prinicipal investigator, Cairo University) — Principal investigator
First posted
Aug 26, 2024
Start date
Sep 1, 2024 (estimated)
Primary completion
Apr 30, 2026 (estimated)
Completion
Apr 30, 2026 (estimated)
Last update
Sep 4, 2024

Study contacts

Ahmed El-Kotaby, Master
Contact
ahmed.elkotaby@dentistry.cu.edu.eg
Egypt +201150961970

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion